Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study.
Chen CK, Yang SY, Park SC, Jang OJ, Zhu X, Xiang YT, Ouyang WC, Javed A, Khan MNS, Grover S, Avasthi A, Kallivayalil RA, Chee KY, Chemi N, Kato TA, Hayakawa K, Pariwatcharakul P, Maramis M, Seneviratne L, Sim K, Tang WK, Oo T, Sartorius N, Tan CH, Chong MY, Park YC, Shinfuku N, Lin SK.
Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
Yin B, Cai Y, Teng T, Wang X, Liu X, Li X, Wang J, Wu H, He Y, Ren F, Kou T, Zhu ZJ, Zhou X.
Transl Psychiatry. 2024 Mar 26;14(1):163. doi: 10.1038/s41398-024-02886-z.
PMID:38531835
Hydrocephalus and bipolar affective disorder.
Rizvi SNA, Whitty M, Daly R.
Ir J Psychol Med. 2011 Dec;28(4):222-223. doi: 10.1017/S0790966700011708.
PMID:30200012
Diagnostic stability in pediatric bipolar disorder.
Vedel Kessing L, Vradi E, Kragh Andersen P.
J Affect Disord. 2015 Feb 1;172:417-21. doi: 10.1016/j.jad.2014.10.037. Epub 2014 Oct 29.
PMID:25451446
Steroid-induced mania in a patient with previously well-controlled organic bipolar 1-like affective disorder secondary to acquired brain injury: case report and literature review.
King JD, Elliott T, Pitman A.
Discov Ment Health. 2024 Mar 8;4(1):8. doi: 10.1007/s44192-024-00061-w.